We are 4-(4-Phenylbutoxy)benzoic Acid CAS:30131-16-9 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
Chemical Name: 4-(4-Phenylbutoxy)benzoic Acid
Benzoic acid, 4-(4-phenylbutoxy)-
Molecular Formula: C17H18O3
Molecular Weight: 270.32300
Physical and Chemical Properties:
Density: 1.122g / cm3
Boiling point: 438ºC at 760mmHg
Flash point: 159.7ºC
Refractive index: 1.577
Appearance: White powder
25kg cardboard drum or according to customer specified requirements
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Intermediates of ranlukast CAS:103177-37-3.
Related News: The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.50-79-3 Coupled with the poor global pesticide industry situation this year, the weakening of downstream customer demand has affected the sales of pesticide intermediates.acetohidrazida CAS:1068-57-1 Coupled with the poor global pesticide industry situation this year, the weakening of downstream customer demand has affected the sales of pesticide intermediates.N-OCTYLMETHYLDIETHOXYSILANE CAS:2652-38-2 These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders — in addition to Ed Damiano — include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant’s collection.